Search Results for: rewalk

[Crowdfund Insider] OurCrowd’s Portfolio Company ReWalk Successfully Launches IPO on NASDAQ

Sep 30, 2014 |

“OurCrowd’s CEO Jon Medved says, ‘OurCrowd is proud of ReWalk and this important achievement. We have now demonstrated that equity crowdfunding can provide an opportunity for individual accredited investors to fund the best of companies. This offering marks the first time an equity crowdfunding platform has accompanied a company over the full cycle, from venture funding through to an IPO on a major US exchange. Moreover, it is truly gratifying to invest in successful companies that dramatically change people’s lives for the better.’...

Read More

RELEASE: OurCrowd’s Portfolio Company ReWalk Launches IPO on NASDAQ

Sep 30, 2014

MATERIALS FOR RELEASE: PDF download here Photos and logos ZIP file download here — OurCrowd’s Portfolio Company ReWalk Launches IPO on NASDAQ IPO marks the first equity crowdfunded company to complete successful public offering Jerusalem, Israel September 30, 2014: OurCrowd, the leading equity crowdfunding platform for accredited investors, announced today that its portfolio company ReWalk Robotics (RWLK) has completed its successful IPO on the NASDAQ. The company issued 3,450,000 million shares and expects to receive total estimated net proceeds from this offering of approximately $36.3 million after deducting estimated underwriting discounts and commissions and estimated offering expenses.  OurCrowd members had previously invested $3.3 million in ReWalk in two separate funding rounds over the past year. OurCrowd had invested alongside leading VCs, such as Pontifax, Israel Health Care Ventures, SCP Vitalife and the Japanese Robotics giant YASKAWA. OurCrowd’s CEO Jon Medved says “OurCrowd is proud of ReWalk and this important achievement. We have now demonstrated that equity crowdfunding can provide an opportunity for individual accredited investors to fund the best of companies. This offering marks the first time an equity crowdfunding...

Read More

OurCrowd’s portfolio company ReWalk featured on Times of Israel

Sep 15, 2014 | ,

OurCrowd portfolio company ReWalk was featured in the Times of Israel, an English-language news website covering Israel, the region & the Jewish world. FDA approved ReWalk has developed an exoskeleton device that enables paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits. With its successful IPO last week, ReWalk, the company behind the Israeli-developed exoskeleton system designed to help paraplegics walk, is ready to go to market. But that’s not all. The highly praised firm is looking past restoring the use of legs to aiding victims of multiple sclerosis (MS), palsy and strokes. There are good reasons for investors to be as excited about ReWalk as paralyzed individuals are. “We are going to be using the money raised in the IPO to expand our research and production, almost all of which is done in northern Israel,” said [company CEO] Jasinski.   ReWalk raised $1,320,000 from OurCrowd investors in June 2013. Read more on the Times of...

Read More

OurCrowd’s portfolio company ReWalk featured in Globes

Aug 27, 2014 | ,

OurCrowd portfolio company ReWalk Robotics was featured in Globes, the leading Israeli financial daily. FDA approved ReWalk has developed an exoskeleton device that enables paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits. ReWalk Robotics has set terms for its Nasdaq IPO. The Yokneam-based company recently changed its name from Argo Medical Technologies to its flagship product, which is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk. The IPO is set to take place in the second week of September.   ReWalk raised $1,320,000 from OurCrowd investors in June 2013. Read more on...

Read More

OurCrowd’s portfolio company ReWalk featured on CBC News

Jul 25, 2014 | ,

OurCrowd portfolio company ReWalk, developer of the FDA approved ReWalk exoskeleton device, was featured on CBC News Network’s “The Lang & O’Leary Exchange.” In the interview, Amanda Lang and Kevin O’Leary talked with ReWalk CEO Larry Jasinski about how the exoskeleton invention provides powered hip and knee motion to enable individuals with a spinal cord injury to stand upright and walk. Improvements in motion sensing technology and the advent of improved computers and batteries helped create a more natural form of motion that is not so difficult to learn for paraplegic users, Jasinski said. “What Dr. Goffer did, he took the concept of using a motion sensor where the person can use their own body to tell this thing how to walk,” he said.   ReWalk raised $1,320,000 from OurCrowd investors in June 2013. Read more and watch the segment on CBC News...

Read More